BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Arthritis
,
Leukocyte
,
Personalized medicine
,
FXYD4
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
GCases
Summary
General Info
Curated Studies
Most Correlated Studies
Gaucher Disease progression in the liver and lungs in disease models in mouse
Explore Curated Studies Results
Literature
Most Relevant Literature
Imaging and genetics in Parkinson's disease: assessment of the GBA1 mutation.
Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease.
Comparison of Transcranial Sonography and [18 F]-Fluorodopa PET Imaging in GBA1 Mutation Carriers.
GBA1-dependent membrane glucosylceramide reprogramming promotes liver cancer metastasis via activati…
False negatives in GBA1 sequencing due to polymerase dependent allelic imbalance.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
MR-guided Focused Ultrasound Plus GCase
Exploration of GCase Activity to Identify a Subpopulation Eligible for a Therapeutic Trial in Dement…
Lentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02 for Subjects With Type 1 Gaucher Dise…
A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Recei…
A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ